Global Antiemetic Drugs Sales Market Report 2021

1 Antiemetic Drugs Market Overview

• 1.1 Antiemetic Drugs Product Scope
• 1.2 Antiemetic Drugs Segment by Type
  • 1.2.1 Global Antiemetic Drugs Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Dopamine Antagonist
  • 1.2.3 5-HT-3 Receptor Antagonist
  • 1.2.4 NK1 Receptor Antagonist
  • 1.2.5 Cannabinoid Receptor Antagonist
• 1.3 Antiemetic Drugs Segment by Application
  • 1.3.1 Global Antiemetic Drugs Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Chemotherapy
  • 1.3.3 Gastroenteritis
  • 1.3.4 Surgery
• 1.4 Antiemetic Drugs Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Antiemetic Drugs Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Antiemetic Drugs Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Antiemetic Drugs Price Trends (2016-2027)

2 Antiemetic Drugs Estimates and Forecasts by Region

• 2.1 Global Antiemetic Drugs Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Antiemetic Drugs Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Antiemetic Drugs Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Antiemetic Drugs Revenue Market Share by Region (2016-2021)
• 2.3 Global Antiemetic Drugs Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Antiemetic Drugs Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Antiemetic Drugs Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Antiemetic Drugs Estimates and Projections (2016-2027)
  • 2.4.2 Europe Antiemetic Drugs Estimates and Projections (2016-2027)
  • 2.4.3 China Antiemetic Drugs Estimates and Projections (2016-2027)
  • 2.4.4 Japan Antiemetic Drugs Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Antiemetic Drugs Estimates and Projections (2016-2027)
  • 2.4.6 India Antiemetic Drugs Estimates and Projections (2016-2027)

3 Global Antiemetic Drugs Competition Landscape by Players

• 3.1 Global Top Antiemetic Drugs Players by Sales (2016-2021)
• 3.2 Global Top Antiemetic Drugs Players by Revenue (2016-2021)
• 3.3 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antiemetic Drugs as of 2020)
• 3.4 Global Antiemetic Drugs Average Price by Company (2016-2021)
• 3.5 Manufacturers Antiemetic Drugs Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Antiemetic Drugs Market Size by Type

• 4.1 Global Antiemetic Drugs Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Antiemetic Drugs Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Antiemetic Drugs Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Antiemetic Drugs Price by Type (2016-2021)
• 4.2 Global Antiemetic Drugs Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Antiemetic Drugs Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Antiemetic Drugs Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Antiemetic Drugs Price Forecast by Type (2022-2027)

5 Global Antiemetic Drugs Market Size by Application

• 5.1 Global Antiemetic Drugs Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Antiemetic Drugs Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Antiemetic Drugs Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Antiemetic Drugs Price by Application (2016-2021)
• 5.2 Global Antiemetic Drugs Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Antiemetic Drugs Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Antiemetic Drugs Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Antiemetic Drugs Price Forecast by Application (2022-2027)

6 North America Antiemetic Drugs Market Facts & Figures

• 6.1 North America Antiemetic Drugs Sales by Company
  • 6.1.1 North America Antiemetic Drugs Sales by Company (2016-2021)
  • 6.1.2 North America Antiemetic Drugs Revenue by Company (2016-2021)
• 6.2 North America Antiemetic Drugs Sales Breakdown by Type
  • 6.2.1 North America Antiemetic Drugs Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Antiemetic Drugs Sales Breakdown by Type (2022-2027)
• 6.3 North America Antiemetic Drugs Sales Breakdown by Application
  • 6.3.1 North America Antiemetic Drugs Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Antiemetic Drugs Sales Breakdown by Application (2022-2027)

7 Europe Antiemetic Drugs Market Facts & Figures

• 7.1 Europe Antiemetic Drugs Sales by Company
  • 7.1.1 Europe Antiemetic Drugs Sales by Company (2016-2021)
  • 7.1.2 Europe Antiemetic Drugs Revenue by Company (2016-2021)
• 7.2 Europe Antiemetic Drugs Sales Breakdown by Type
  • 7.2.1 Europe Antiemetic Drugs Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Antiemetic Drugs Sales Breakdown by Type (2022-2027)
• 7.3 Europe Antiemetic Drugs Sales Breakdown by Application
  • 7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China Antiemetic Drugs Market Facts & Figures

• 8.1 China Antiemetic Drugs Sales by Company
  • 8.1.1 China Antiemetic Drugs Sales by Company (2016-2021)
  • 8.1.2 China Antiemetic Drugs Revenue by Company (2016-2021)
• 8.2 China Antiemetic Drugs Sales Breakdown by Type
  • 8.2.1 China Antiemetic Drugs Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Antiemetic Drugs Sales Breakdown by Type (2022-2027)
• 8.3 China Antiemetic Drugs Sales Breakdown by Application
  • 8.3.1 China 164 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 164 Sales Breakdown by Application (2022-2027)

9 Japan Antiemetic Drugs Market Facts & Figures

• 9.1 Japan Antiemetic Drugs Sales by Company
  • 9.1.1 Japan Antiemetic Drugs Sales by Company (2016-2021)
  • 9.1.2 Japan Antiemetic Drugs Revenue by Company (2016-2021)
• 9.2 Japan Antiemetic Drugs Sales Breakdown by Type
  • 9.2.1 Japan Antiemetic Drugs Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Antiemetic Drugs Sales Breakdown by Type (2022-2027)
• 9.3 Japan Antiemetic Drugs Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Antiemetic Drugs Market Facts & Figures

• 10.1 Southeast Asia Antiemetic Drugs Sales by Company
  • 10.1.1 Southeast Asia Antiemetic Drugs Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Antiemetic Drugs Revenue by Company (2016-2021)
• 10.2 Southeast Asia Antiemetic Drugs Sales Breakdown by Type
  • 10.2.1 Southeast Asia Antiemetic Drugs Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Antiemetic Drugs Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Antiemetic Drugs Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Antiemetic Drugs Market Facts & Figures

• 11.1 India Antiemetic Drugs Sales by Company
  • 11.1.1 India Antiemetic Drugs Sales by Company (2016-2021)
  • 11.1.2 India Antiemetic Drugs Revenue by Company (2016-2021)
• 11.2 India Antiemetic Drugs Sales Breakdown by Type
  • 11.2.1 India Antiemetic Drugs Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Antiemetic Drugs Sales Breakdown by Type (2022-2027)
• 11.3 India Antiemetic Drugs Sales Breakdown by Application
  • 11.3.1 India Antiemetic Drugs Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Antiemetic Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Antiemetic Drugs Business

• 12.1 GlaxoSmithKline
  • 12.1.1 GlaxoSmithKline Corporation Information
  • 12.1.2 GlaxoSmithKline Business Overview
  • 12.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 GlaxoSmithKline Antiemetic Drugs Products Offered
  • 12.1.5 GlaxoSmithKline Recent Development
• 12.2 Johnson & Johnson
  • 12.2.1 Johnson & Johnson Corporation Information
  • 12.2.2 Johnson & Johnson Business Overview
  • 12.2.3 Johnson & Johnson Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Johnson & Johnson Antiemetic Drugs Products Offered
  • 12.2.5 Johnson & Johnson Recent Development
• 12.3 Pfizer
  • 12.3.1 Pfizer Corporation Information
  • 12.3.2 Pfizer Business Overview
  • 12.3.3 Pfizer Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Pfizer Antiemetic Drugs Products Offered
  • 12.3.5 Pfizer Recent Development
• 12.4 Sanofi
  • 12.4.1 Sanofi Corporation Information
  • 12.4.2 Sanofi Business Overview
  • 12.4.3 Sanofi Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Sanofi Antiemetic Drugs Products Offered
  • 12.4.5 Sanofi Recent Development
• 12.5 Abbott
  • 12.5.1 Abbott Corporation Information
  • 12.5.2 Abbott Business Overview
  • 12.5.3 Abbott Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Abbott Antiemetic Drugs Products Offered
  • 12.5.5 Abbott Recent Development
• 12.6 Bristol-Myers Squibb
  • 12.6.1 Bristol-Myers Squibb Corporation Information
  • 12.6.2 Bristol-Myers Squibb Business Overview
  • 12.6.3 Bristol-Myers Squibb Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Bristol-Myers Squibb Antiemetic Drugs Products Offered
  • 12.6.5 Bristol-Myers Squibb Recent Development
• 12.7 Cipla
  • 12.7.1 Cipla Corporation Information
  • 12.7.2 Cipla Business Overview
  • 12.7.3 Cipla Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Cipla Antiemetic Drugs Products Offered
  • 12.7.5 Cipla Recent Development
• 12.8 Eisai
  • 12.8.1 Eisai Corporation Information
  • 12.8.2 Eisai Business Overview
  • 12.8.3 Eisai Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Eisai Antiemetic Drugs Products Offered
  • 12.8.5 Eisai Recent Development
• 12.9 Eli Lilly
  • 12.9.1 Eli Lilly Corporation Information
  • 12.9.2 Eli Lilly Business Overview
  • 12.9.3 Eli Lilly Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Eli Lilly Antiemetic Drugs Products Offered
  • 12.9.5 Eli Lilly Recent Development
• 12.10 Glenmark
  • 12.10.1 Glenmark Corporation Information
  • 12.10.2 Glenmark Business Overview
  • 12.10.3 Glenmark Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Glenmark Antiemetic Drugs Products Offered
  • 12.10.5 Glenmark Recent Development
• 12.11 Helsinn Healthcare
  • 12.11.1 Helsinn Healthcare Corporation Information
  • 12.11.2 Helsinn Healthcare Business Overview
  • 12.11.3 Helsinn Healthcare Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Helsinn Healthcare Antiemetic Drugs Products Offered
  • 12.11.5 Helsinn Healthcare Recent Development
• 12.12 Heron Therapeutics
  • 12.12.1 Heron Therapeutics Corporation Information
  • 12.12.2 Heron Therapeutics Business Overview
  • 12.12.3 Heron Therapeutics Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Heron Therapeutics Antiemetic Drugs Products Offered
  • 12.12.5 Heron Therapeutics Recent Development
• 12.13 IPCA Laboratories
  • 12.13.1 IPCA Laboratories Corporation Information
  • 12.13.2 IPCA Laboratories Business Overview
  • 12.13.3 IPCA Laboratories Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 IPCA Laboratories Antiemetic Drugs Products Offered
  • 12.13.5 IPCA Laboratories Recent Development
• 12.14 Lupin
  • 12.14.1 Lupin Corporation Information
  • 12.14.2 Lupin Business Overview
  • 12.14.3 Lupin Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Lupin Antiemetic Drugs Products Offered
  • 12.14.5 Lupin Recent Development
• 12.15 Merck
  • 12.15.1 Merck Corporation Information
  • 12.15.2 Merck Business Overview
  • 12.15.3 Merck Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Merck Antiemetic Drugs Products Offered
  • 12.15.5 Merck Recent Development
• 12.16 Novartis
  • 12.16.1 Novartis Corporation Information
  • 12.16.2 Novartis Business Overview
  • 12.16.3 Novartis Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Novartis Antiemetic Drugs Products Offered
  • 12.16.5 Novartis Recent Development
• 12.17 RedHill
  • 12.17.1 RedHill Corporation Information
  • 12.17.2 RedHill Business Overview
  • 12.17.3 RedHill Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 RedHill Antiemetic Drugs Products Offered
  • 12.17.5 RedHill Recent Development
• 12.18 Sun Pharmaceutical Industries
  • 12.18.1 Sun Pharmaceutical Industries Corporation Information
  • 12.18.2 Sun Pharmaceutical Industries Business Overview
  • 12.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Products Offered
  • 12.18.5 Sun Pharmaceutical Industries Recent Development
• 12.19 Takeda Pharmaceutical
  • 12.19.1 Takeda Pharmaceutical Corporation Information
  • 12.19.2 Takeda Pharmaceutical Business Overview
  • 12.19.3 Takeda Pharmaceutical Antiemetic Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.19.4 Takeda Pharmaceutical Antiemetic Drugs Products Offered
  • 12.19.5 Takeda Pharmaceutical Recent Development

13 Antiemetic Drugs Manufacturing Cost Analysis

• 13.1 Antiemetic Drugs Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Antiemetic Drugs
• 13.4 Antiemetic Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Antiemetic Drugs Distributors List
• 14.3 Antiemetic Drugs Customers

15 Market Dynamics

• 15.1 Antiemetic Drugs Market Trends
• 15.2 Antiemetic Drugs Drivers
• 15.3 Antiemetic Drugs Market Challenges
• 15.4 Antiemetic Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List